Global News and Digital Insights
for the Healthcare Industry

Day: March 14, 2023

ZavzpretTM nasal spray for migraine gets FDA approval

ZavzpretTM (zavegepant) nasal spray, a calcitonin gene-related peptide (CGRP) receptor antagonist, has been authorised by the Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults.

ZavzpretTM nasal spray for migraine gets FDA approval

ZavzpretTM (zavegepant) nasal spray, a calcitonin gene-related peptide (CGRP) receptor antagonist, has been authorised by the Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults.